XML 18 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash flows from operating activities    
Net income $ 701.3 $ 729.2
Reconciliation of net income to net cash provided by operating activities:    
Depreciation and amortization 93.8 84.8
Stock-based compensation expense 72.8 66.5
Deferred income taxes 7.1 19.7
Excess tax benefits from stock-based compensation plans (32.4) (44.5)
Legacy Tax Matters (1.6) (6.4)
Changes in assets and liabilities:    
Accounts receivable (35.6) 61.0
Other current assets 51.1 4.9
Other assets 10.2 (6.6)
Accounts payable and accrued liabilities (54.6) (35.7)
Deferred revenue 31.2 10.6
Unrecognized tax benefits and other non-current tax liabilities (1.8) (9.9)
Other liabilities 15.1 19.9
Net cash provided by operating activities 856.6 893.5
Cash flows from investing activities    
Capital additions (84.8) (65.9)
Purchases of investments (279.7) (480.4)
Sales and maturities of investments 438.7 448.6
Acquisitions, net of cash required (79.1) (4.6)
Settlement of net investment hedges 2.5 20.8
Net cash used in investing activities (2.4) (81.5)
Cash flows from financing activities    
Issuance of notes   552.8
Proceeds from stock-based compensation plans 72.5 72.1
Repurchase of shares for payroll tax withholdings related to stock-based compensation (44.0) (59.3)
Cost of treasury shares repurchased (678.9) (905.6)
Excess tax benefits from settlement of stock-based compensation plans 32.4 44.5
Payment of dividends (214.5) (205.0)
Acquisition of NCI (45.4)  
Payment of dividends to noncontrolling interests (4.6) (4.6)
Contingent consideration paid   (1.5)
Debt issuance costs and related fees (0.1) (5.9)
Net cash (used in) provided by financing activities (882.6) (512.5)
Effect of exchange rate changes on cash and cash equivalents 17.1 (47.9)
Net increase (decrease) in cash and cash equivalents (11.3) 251.6
Cash and cash equivalents, beginning of the period 1,757.4 1,219.5
Cash and cash equivalents, end of the period $ 1,746.1 $ 1,471.1